会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Catalytically active recombinant memapsin and methods of use thereof
    • 催化活性重组膜突触蛋白及其使用方法
    • US20080112946A1
    • 2008-05-15
    • US11888920
    • 2007-08-03
    • Gerald KoelschJordan J. N. TangLin HongArun K. GhoshXinli Lin
    • Gerald KoelschJordan J. N. TangLin HongArun K. GhoshXinli Lin
    • A61K38/46C12N9/52C12P21/04
    • C07K5/1021A61K38/00A61K39/00C07K1/1136C07K5/06026C07K5/06043C07K5/0806C07K2299/00C12N9/6421C12N9/6478Y02A90/26Y10S514/879
    • Methods for the production of purified, catalytically active, recombinant memapsin 2 have been developed. The substrate and subsite specificity of the catalytically active enzyme have been determined. The substrate and subsite specificity information was used to design substrate analogs of the natural memapsin 2 substrate that can inhibit the function of memapsin 2. The substrate analogs are based on peptide sequences, shown to be related to the natural peptide substrates for memapsin 2. The substrate analogs contain at least one analog of an amide bond which is not capable of being cleaved by memapsin 2. Processes for the synthesis of two substrate analogues including isosteres at the sites of the critical amino acid residues were developed and the substrate analogues, OMR99-1 and OM99-2, were synthesized. OM99-2 is based on an octapeptide Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe (SEQ ID NO:28) with the Leu-Ala peptide bond substituted by a transition-state isostere hydroxyethylene group (FIG. 1). The inhibition constant of OM99-2 is 1.6×10−9 M against recombinant pro-memapsin 2. Crystallography of memapsin 2 bond to this inhibitor was used to determine the three dimensional structure of the protein, as well as the importance of the various residues in binding. This information can be used by those skilled in the art to design new inhibitors, using commercially available software programs and techniques familiar to those in organic chemistry and enzymology, to design new inhibitors to memapsin 2, useful in diagnostics and for the treatment and/or prevention of Alzheimer's disease.
    • 已经开发了用于生产纯化的,催化活性的重组突变蛋白2的方法。 已经确定了催化活性酶的底物和亚位点特异性。 底物和亚位点特异性信息用于设计可以抑制膜蛋白2功能的天然memapsin 2底物的底物类似物。底物类似物基于肽序列,显示与memapsin 2的天然肽底物相关。 底物类似物含有至少一个酰胺键的类似物,该类似物不能被膜蛋白2切割。开发了两个底物类似物合成的关键氨基酸残基位点处的等位基因,底物类似物OMR99- 1和OM99-2。 OM99-2基于由过渡态等电位羟基亚乙基取代的Leu-Ala肽键的八肽Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe(SEQ ID NO:28)(图1 )。 OM99-2的抑制常数相对于重组前体蛋白2是1.6×10 -9 M。使用与该抑制剂的膜蛋白2键的结晶学来确定蛋白质的三维结构,以及 各种残留物在结合中的重要性。 本领域技术人员可以使用本信息来设计新的抑制剂,使用商业上可获得的有机化学和酶学方面熟悉的软件程序和技术来设计新的抑制剂2,可用于诊断和治疗和/或 预防阿尔茨海默病。
    • 2. 发明授权
    • Catalytically active recombinant memapsin and methods of use thereof
    • 催化活性重组膜突触蛋白及其使用方法
    • US07829669B2
    • 2010-11-09
    • US11888920
    • 2007-08-03
    • Gerald KoelschJordan J. N. TangLin HongArun K. GhoshXinli Lin
    • Gerald KoelschJordan J. N. TangLin HongArun K. GhoshXinli Lin
    • C07K1/00
    • C07K5/1021A61K38/00A61K39/00C07K1/1136C07K5/06026C07K5/06043C07K5/0806C07K2299/00C12N9/6421C12N9/6478Y02A90/26Y10S514/879
    • Methods for the production of purified, catalytically active, recombinant memapsin 2 have been developed. The substrate and subsite specificity of the catalytically active enzyme have been determined. The substrate and subsite specificity information was used to design substrate analogs of the natural memapsin 2 substrate that can inhibit the function of memapsin 2. The substrate analogs are based on peptide sequences, shown to be related to the natural peptide substrates for memapsin 2. The substrate analogs contain at least one analog of an amide bond which is not capable of being cleaved by memapsin 2. Processes for the synthesis of two substrate analogues including isosteres at the sites of the critical amino acid residues were developed and the substrate analogues, OMR99-1 and OM99-2, were synthesized. OM99-2 is based on an octapeptide Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe (SEQ ID NO:28) with the Leu-Ala peptide bond substituted by a transition-state isostere hydroxyethylene group (FIG. 1). The inhibition constant of OM99-2 is 1.6×10−9 M against recombinant pro-memapsin 2. Crystallography of memapsin 2 bond to this inhibitor was used to determine the three dimensional structure of the protein, as well as the importance of the various residues in binding. This information can be used by those skilled in the art to design new inhibitors, using commercially available software programs and techniques familiar to those in organic chemistry and enzymology, to design new inhibitors to memapsin 2, useful in diagnostics and for the treatment and/or prevention of Alzheimer's disease.
    • 已经开发了用于生产纯化的,催化活性的重组突变蛋白2的方法。 已经确定了催化活性酶的底物和亚位点特异性。 底物和亚位点特异性信息用于设计可以抑制膜蛋白2功能的天然memapsin 2底物的底物类似物。底物类似物基于肽序列,显示与memapsin 2的天然肽底物相关。 底物类似物含有至少一个酰胺键的类似物,该类似物不能被膜蛋白2切割。开发了两个底物类似物合成的关键氨基酸残基位点处的等位基因,底物类似物OMR99- 1和OM99-2。 OM99-2基于由过渡态等电位羟基亚乙基取代的Leu-Ala肽键的八肽Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe(SEQ ID NO:28)(图1 )。 OM99-2的抑制常数为1.6×10-9M,与重组前胶原蛋白2相似。蛋白2的结构与该抑制剂结合使用,用于测定蛋白质的三维结构,以及各种残基的重要性 绑定。 本领域技术人员可以使用本信息来设计新的抑制剂,使用商业上可获得的有机化学和酶学方面熟悉的软件程序和技术来设计新的抑制剂2,可用于诊断和治疗和/或 预防阿尔茨海默病。
    • 3. 发明授权
    • Catalytically active recombinant memapsin and methods of use thereof
    • 催化活性重组膜突触蛋白及其使用方法
    • US06545127B1
    • 2003-04-08
    • US09604608
    • 2000-06-27
    • Jordan J. N. TangXinli LinGerald KoelschLin Hong
    • Jordan J. N. TangXinli LinGerald KoelschLin Hong
    • G01N3348
    • C07K5/1021A61K38/00A61K39/00C07K1/1136C07K5/06026C07K5/06043C07K5/0806C07K2299/00C12N9/6421C12N9/6478Y02A90/26Y10S514/879
    • Methods for the production of purified, catalytically active, recombinant memapsin 2 have been developed. The substrate and subsite specificity of the catalytically active enzyme have been determined. The substrate and subsite specificity information was used to design substrate analogs of the natural memapsin 2 substrate that can inhibit the function of memapsin 2. The substrate analogs are based on peptide sequences, shown to be related to the natural peptide substrates for memapsin 2. The substrate analogs contain at least one analog of an amide bond which is not capable of being cleaved by memapsin 2. Processes for the synthesis of two substrate analogues including isosteres at the sites of the critical amino acid residues were developed and the substrate analogues, OMR99-1 and OM99-2, were synthesized. OM99-2 is based on an octapeptide Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe (SEQ ID NO:28) with the Leu-Ala peptide bond substituted by a transition-state isostere hydroxyethylene group (FIG. 1). The inhibition constant of OM99-2 is 1.6×10−9M against recombinant pro-memapsin 2. Crystallography of memapsin 2 bound to this inhibitor was used to determine the three dimensional structure of the protein, as well as the importance of the various residues in binding. This information can be used by those skilled in the art to design new inhibitors, using commercially available software programs and techniques familiar to those in organic chemistry and enzymology, to design new inhibitors to memapsin 2, useful in diagnostics and for the treatment and/or prevention of Alzheimer's disease.
    • 已经开发了用于生产纯化的,催化活性的重组突变蛋白2的方法。 已经确定了催化活性酶的底物和亚位点特异性。 底物和亚位点特异性信息用于设计可以抑制膜蛋白2功能的天然memapsin 2底物的底物类似物。底物类似物基于肽序列,显示与memapsin 2的天然肽底物相关。 底物类似物含有至少一个酰胺键的类似物,该类似物不能被膜蛋白2切割。开发了两个底物类似物合成的关键氨基酸残基位点处的等位基因,底物类似物OMR99- 1和OM99-2。 OM99-2基于由过渡态等电位羟基亚乙基取代的Leu-Ala肽键的八肽Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe(SEQ ID NO:28)(图1 )。 OM99-2的抑制常数为1.6×10 -9 M,与重组pro-memapsin2结合使用与此抑制剂结合的胶原蛋白2的结晶学,以确定蛋白质的三维结构,以及各种残基在结合中的重要性 。 本领域技术人员可以使用本信息来设计新的抑制剂,使用商业上可获得的有机化学和酶学方面熟悉的软件程序和技术来设计新的抑制剂2,可用于诊断和治疗和/或 预防阿尔茨海默病。
    • 8. 发明申请
    • Methods and Apparatus for Automatic Body Part Identification and Localization
    • 自动身体部位识别和定位的方法和装置
    • US20080112605A1
    • 2008-05-15
    • US11933518
    • 2007-11-01
    • Lin HongShen Hong
    • Lin HongShen Hong
    • A61B5/00
    • G06T7/74G06T2207/30004
    • Methods and apparatus are disclosed for automatically identifying and locating body parts in medical imaging. To automatically identify body parts of in an image, an identification and location algorithm is used. This establishes a reference frame in relation to the image. Then, a location of the head in relation to the frame is established. After upper and lower boundaries of the head are determined, a neck section of the image is identified. The neck section is identified using the lower boundary of the head section. The location of the neck section is then found. A thorax cage section is found and located positively below the neck section. The abdomen and pelvis are identified together and ultimately separately located and identified.
    • 公开了用于在医学成像中自动识别和定位身体部位的方法和装置。 为了自动识别图像中的身体部位,使用识别和位置算法。 这建立了与图像相关的参考帧。 然后,建立头部相对于框架的位置。 在确定头部的上边界和下边界之后,识别图像的颈部。 使用头部的下边界识别颈部。 然后找到颈部的位置。 发现一个胸部保持架部分,并正确地位于颈部部分。 腹部和骨盆被一起识别,最终分开定位和识别。
    • 10. 发明申请
    • APPARATUS FOR ADJUSTING INCLINATION OF CHAIR BACKS
    • 调整椅背的装置
    • US20050168029A1
    • 2005-08-04
    • US10768592
    • 2004-01-30
    • Lin Hong
    • Lin Hong
    • A47C1/024A47C1/026A47C1/032A47C7/00A47C7/40G05G5/06
    • A47C1/03255A47C1/03238
    • An apparatus for adjusting the inclination of a chair back, is disposed on the chassis at the bottom of a cushion and pivotally coupled to the middle of a base at the upper end of chair legs. A control rod has its middle predetermined position pivotally coupled to the base. A positioning plate has a bolt at its top surface and is disposed at the rear end of the base. A resilient component is pivotally coupled such that one end of the resilient component is hooked into an end of the control rod, and the other end of the resilient component being hooked into the bolt at the top surface of the positioning plate. When the control rod is turned to swing its end, the resilient component rotates, so that one of the resilient legs of the resilient component produces an elastic push onto the positioning plate. Thus the positioning plate contracts and moves to embed into or withdrawal from a latch groove disposed at the bottom rear side of the chassis. Therefore, the pushing force of a spring can be acted completely on the positioning plate and the positioning plate can move smoother, making operation easier and simpler.
    • 一种用于调节椅子背部倾斜度的装置设置在底座上的垫子的底部,并在椅腿的上端枢转地联接到基座的中部。 控制杆具有枢转地联接到基座的中间预定位置。 定位板在其顶面具有螺栓,并且设置在基座的后端。 弹性部件被枢转地联接,使得弹性部件的一端钩在控制杆的一端中,并且弹性部件的另一端被钩在定位板的顶表面处的螺栓中。 当控制杆转动以摆动其端部时,弹性部件旋转,使得弹性部件的弹性腿之一产生弹性推动到定位板上。 因此,定位板收缩并移动以嵌入到设置在底盘的后后侧的闩锁槽或从其中取出。 因此,弹簧的推力可以完全作用在定位板上,定位板可以更平稳地移动,使操作更简单。